FDA
-
-
-
-
-
-
-
FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
-
-
-
-
-
-
-
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
-
-
-
-
-
-
-
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
-
330,738 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

